Quinn Opportunity Partners LLC REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 136 filers reported holding REVANCE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.5%.

Quinn Opportunity Partners LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$371
+64.9%
15,2000.0%0.05%
+35.3%
Q1 2020$225
-87.8%
15,200
-86.6%
0.03%
-71.9%
Q4 2019$1,842
+165.4%
113,544
+112.6%
0.12%
+44.0%
Q3 2019$694
+1.6%
53,400
+1.4%
0.08%
-1.2%
Q2 2019$683
-23.5%
52,672
-7.1%
0.08%
-30.3%
Q1 2019$893
-21.7%
56,6720.0%0.12%
-23.3%
Q4 2018$1,141
-21.7%
56,672
-3.4%
0.16%
-23.2%
Q3 2018$1,458
+60.4%
58,672
+77.3%
0.21%
+71.1%
Q2 2018$909
+224.6%
33,100
+263.7%
0.12%
+236.1%
Q1 2018$280
-13.8%
9,1000.0%0.04%
-33.3%
Q4 2017$3259,1000.05%